Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients
Christoph Ehlken,1,2 Mandy Helms,1 Daniel Böhringer,1 Hansjürgen T Agostini,1 Andreas Stahl1 1Ophthalmology, Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, 2Ophthalmology, Eye Center, University Hospital Schleswig-Holstein, Campus Ki...
Guardado en:
Autores principales: | Ehlken C, Helms M, Böhringer D, Agostini HT, Stahl A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e0bc1a851b94451283f13bc9504d800a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Real-World Data: Ranibizumab Treatment For Retinal Vein Occlusion In The OCEAN Study
por: Callizo J, et al.
Publicado: (2019) -
The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey
por: Varano M, et al.
Publicado: (2016) -
Compositional modeling and simulation of dimethyl ether (DME)-enhanced waterflood to investigate oil mobility improvement
por: Jinhyung Cho, et al.
Publicado: (2018) -
Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
por: Veluswamy B, et al.
Publicado: (2020) -
Microvascular Structure Changes After Intravitreal Ranibizumab Injection in Retinal Vein Occlusion Patients With and Without Macular Ischemia
por: Ziyi Zhu, et al.
Publicado: (2021)